Antiglaucoma medications: a review of safety and tolerability issues related to their use

JS Schuman - Clinical therapeutics, 2000 - Elsevier
BACKGROUND: Much experience has been gained with the use of older classes of
antiglaucoma agents—topical beta-adrenergic-receptor antagonists, nonselective …

β-Blocker–induced complications and the patient with glaucoma: newer treatments to help reduce systemic adverse events

WC Stewart, PM Garrison - Archives of Internal Medicine, 1998 - jamanetwork.com
Primary open-angle glaucoma is a condition associated with an elevated intraocular pres-
sure (IOP) that is defined as optic nerve degeneration with a slowly progressive dete …

Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice

YF Chen, AJ Avery, KE Neil, C Johnson, ME Dewey… - Drug Safety, 2005 - Springer
Background: Preventing the use of medications where there is the potential for serious drug-
drug interactions or drug-disease interactions (contraindications) is essential to ensure …

Chronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms

S Deokule, S Sadiq, S Shah - Ophthalmic and Physiological …, 2004 - Wiley Online Library
Purpose: To study the awareness of the nature of the disease, compliance with treatment,
and prevalence of systemic symptoms in a group of patients with chronic open angle …

Association between ophthalmic timolol and hospitalisation for bradycardia

NL Pratt, EN Ramsay, LM Kalisch Ellett… - Journal of …, 2015 - Wiley Online Library
Introduction. Ophthalmic timolol, a topical nonselective beta‐blocker, has the potential to be
absorbed systemically which may cause adverse cardiovascular effects. This study was …

Efficacy and systemic side‐effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel

H Uusitalo, J Nino, K Tahvanainen… - Acta …, 2005 - Wiley Online Library
Purpose: The objective of this randomized, double‐blind, controlled crossover trial was to
compare 0.1% timolol hydrogel formulation eyedrops with 0.5% timolol aqueous solution in …

Medical treatment of glaucoma--a reappraisal of the risks.

P Diggory, W Franks - The British journal of ophthalmology, 1996 - ncbi.nlm.nih.gov
There has been an accumulation of evidence in recent years to demonstrate that surgical
treatment is more effective than eyedrops at lowering intraocular pressure and preserving …

Short-and long-term safety of glaucoma drugs

JS Schuman - Expert Opinion on Drug Safety, 2002 - Taylor & Francis
Glaucoma, a leading cause of blindness worldwide, is a chronic neurodegenerative
disorder. Patients with glaucoma may require long-term administration of intraocular …

Asthma in older people

Dow - Clinical & Experimental Allergy, 1998 - Wiley Online Library
From the clinical perspective, asthma in the older patient may be difficult to diagnose
because of the non‐specificity of presentation and the wide range of differential diagnoses …

Dyspnoea in the elderly: a clinical approach to diagnosis

JC Yernault - Drugs & aging, 2001 - Springer
This review briefly overviews the pathophysiology of dyspnoea and then focuses on
discussion of the most frequent causes of chronic and acute dyspnoea in the elderly. The …